Skip to content
★ Sign in to follow
덴티

덴티스 Stock: price and insider trades · South Korea

KR·Mcap ₩39.7BHealth Care

No insider purchase over the last 90 days. The latest, by 심기봉, was filed 07 Aug 2026.

덴티스: what insiders have been doing

덴티스, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Between 2 November 2025 and 2 November 2026, 3 insiders published 9 filings.

Only purchases show up on the open market, 6 purchases in all, filed by 3 insiders. The amount is not disclosed for 6 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 major shareholder, 1 board member and 1 chief executive among the declarants.

The last purchase on record was published on 7 August 2026, which is 93 days ago. The median gap between a trade and its publication by DART (FSS) is 4 days. This delay matters because a trade only becomes useful information once it is public.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 9 filings here. The full history, which starts in 2021, counts 22 purchases against no sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
42
Thresholds
n/a
Buy Volume
€3M
22 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
심기봉4 buys
Nh투자증권1 buy
심형1 buy
Fundamental score
Ranked 24,436 of 26,897 companies
20.8
score / 100
Value
7
Quality
35
FCF yld-35%
Earn yld-36%
EV/EBITDA·
ROE-0.5%
Gross mgn43%
Net mgn-12%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,510
Analyst consensus
·
Income statement
Revenue₩114.2B
Gross profit₩49.5B43% margin
EBITDA-₩4.5B-4% margin
Net income-₩14.2B1.3% margin
Valuation
Beta0.52
Balance sheet & cash
Market cap₩39.7B
Total debt₩105.9B
Free Cash Flow-₩13.6B
Debt / Equity170%
Profitability & ownership
ROE-0.5%
ROA-1.6%
% insiders28.5%
% institutions0.0%
Last declaration on 7 August 2026
Declarations52 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    €20kest.0DART
    11,224 sharesShareKRXDART:20260807000728
    Canonical exit: 5 Nov 2026 (T+90)
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    €8,055est.0DART
    5,373 sharesShareKRXDART:20260731000802
    Canonical exit: 29 Oct 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €25kest.0DART
    16,942 sharesShareKRXDART:20260727000407
    Canonical exit: 26 Oct 2026 (T+90)
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260327001314
  • ▲
    Executives
    €84kest.0DART
    34,508 sharesKRXDART:20260116000297
    Canonical exit: 12 Apr 2026 (T+90)
  • ▲
    사내이사Executives(filed)
    €25kest.0DART
    10,359 sharesShareKRXDART:20260116000283
    Canonical exit: 16 Apr 2026 (T+90)
  • ▲
    대량보유자Executives
    €1.5Mest.0DART
    531,892 sharesKRXDART:20251106000297
    Canonical exit: 26 Jan 2026 (T+90)
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20241115000311
  • ▲
    Executives
    €1.1Mest.0DART
    212,983 sharesKRXDART:20240906000418
    Canonical exit: 20 Nov 2024 (T+90)

25 of 52 declarations

About 덴티스

DENTIS is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of innovative dental products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations